Valosin containing protein (VCP): initiator, modifier, and potential drug target for neurodegenerative diseases
Abstract The AAA+ ATPase valosin containing protein (VCP) is essential for cell and organ homeostasis, especially in cells of the nervous system. As part of a large network, VCP collaborates with many cofactors to ensure proteostasis under normal, stress, and disease conditions. A large number of mu...
Main Authors: | Siwei Chu, Xinyi Xie, Carla Payan, Ursula Stochaj |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-08-01
|
Series: | Molecular Neurodegeneration |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13024-023-00639-y |
Similar Items
-
Valosin-Containing Protein (VCP/p97) Is a Potential Antiviral Target against Mononegavirales
by: Victor Latorre, et al.
Published: (2020-06-01) -
2024 VCP International Conference: Exploring multi-disciplinary approaches from basic science of valosin containing protein, an AAA+ ATPase protein, to the therapeutic advancement for VCP-associated multisystem proteinopathy
by: A. Peck, et al.
Published: (2025-04-01) -
Valosin-containing-protein pathogenic variant p.R487H in Parkinson’s disease
by: Capucine Piat, et al.
Published: (2024-01-01) -
The Co-Chaperone HspBP1 Is a Novel Component of Stress Granules that Regulates Their Formation
by: Hicham Mahboubi, et al.
Published: (2020-03-01) -
The Biogenesis of Dengue Virus Replication Organelles Requires the ATPase Activity of Valosin-Containing Protein
by: Clément Mazeaud, et al.
Published: (2021-10-01)